David Sumerauer

4.8k citations
48 papers · 443 indexed · h-index 12
Topics
Glioma Diagnosis and Treatment (18 papers)Sarcoma Diagnosis and Treatment (12 papers)Neuroblastoma Research and Treatments (8 papers)

In The Last Decade

David Sumerauer

40 papers receiving 432 citations

Peers

David Sumerauer
Comparison fields: 5 of 51
  • Molecular Biology 171
  • Oncology 125
  • Pulmonary and Respiratory Medicine 123
  • Genetics 119
  • Neurology 107
Replace Deb A. Bhowmick with:
Deb A. Bhowmick United States
Cinzia Candiotto Italy
Isabelle Quintin‐Roué France
Georg Schwarzkopf Germany
Hiroaki Sakamoto Japan
Surya P. Rednam United States
Laura S. Hiemcke‐Jiwa Netherlands
P Theunissen Netherlands
S.P. Hector Spain
Felicity Murphy United Kingdom
David Sumerauer relative to Deb A. Bhowmick United States Deb A. Bhowmick's profile →
Citations per field
00.5×1.5×1.8×
Deb A. Bhowmick · 1×
Citations per year

Countries citing papers authored by David Sumerauer

Since Specialization
Citations

This map shows the geographic impact of David Sumerauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sumerauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sumerauer more than expected).

Fields of papers citing papers by David Sumerauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sumerauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sumerauer. The network helps show where David Sumerauer may publish in the future.

Co-authorship network of co-authors of David Sumerauer

This figure shows the co-authorship network connecting the top 25 collaborators of David Sumerauer. A scholar is included among the top collaborators of David Sumerauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sumerauer. David Sumerauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 1
5 3
6 3
7 8
8 13
9 19
10 13
11 12
12 7
13 22
14 45
15 6
16 57
17 54
18 12
19 6
20 3

About David Sumerauer

David Sumerauer is a scholar working on Genetics, Neurology and Pulmonary and Respiratory Medicine, having authored 48 papers that have together received 443 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (18 papers), Sarcoma Diagnosis and Treatment (12 papers) and Neuroblastoma Research and Treatments (8 papers). The work is most often cited by research in Genetics (119 citations), Neurology (107 citations) and Pathology and Forensic Medicine (96 citations). David Sumerauer has collaborated with scholars based in Czechia, Germany and United States. Frequent co-authors include Roman Kodet, Zdeněk Sedláček, Lenka Krsková, Marie Trková, Marcela Mrhalová, Edita Kabíčková, Otakar Bělohlávek, Josef Zámečnı́k, Marie Hladíková and Martin Kynčl. Their work appears in journals such as Blood, PLoS ONE and PEDIATRICS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026